Integrated Biochemo-catalysis for Asymmetric Arylation
Integrated Biochemo-catalysis for Asymmetric Arylation
批准号:
2752680
负责人:
金额:
$0.0万
依托单位:
依托单位国家:
英国
项目类别:
Studentship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --
中文摘要
化学和生物催化的整合提供了一种可持续的分子制造方法,可以实现无废物合成,催化或无金属替代现有试剂,以及一种在简化工艺复杂性和成本的同时增加分子复杂性的新方法。从这个角度来处理合成将是未来化学的关键,其中所有相互关联的因素(试剂,溶剂,产率,中间体,催化剂等)可以系统地优化最佳合成路线。然而,挑战是巨大的-我们如何为酶和化学系统创造相互兼容的反应条件,考虑到通常截然不同的要求(特别是温度和溶剂)?化学催化和生物催化的整合代表了一个新兴的研究领域,将成为未来化学和制造业的核心,这些活动对我们社会的福利和运作至关重要。这两种催化机制是高度互补的,化学催化提供了强大的C-C键策略,可以与酶控制的不对称官能团转化相结合-这是一种受到生物合成理想性启发的方法。不依赖贵金属催化的芳基化对当前化学思想具有挑战性和高度影响力,为参与该项目的iCAT学生创造了高影响力的出版物。该项目将提供生物催化,光氧化还原催化,有机催化,蛋白质表达和纯化,生物测定,不对称合成和水化学等领域的培训,满足CDT的使命声明,以培养下一代科学家,他们可以在化学连续体中操作,并为未来在不断变化的敏捷行业中的领导角色做好准备。该项目是从Greaney和Turner实验室在综合催化方面的长期合作中发展起来的,该合作在生物氧化还原和C-H芳基化方面取得了进展,提供了一个合作者,设备和想法的支持框架,iCAT学生可以实现雄心勃勃的研究目标。Turner和Greaney团队都与工业集团(例如先正达,AZ,GSK)围绕提案中提出的芳基化和生物催化转化概念进行了广泛的合作,为项目带来了最终用户互动,并帮助学生在研究生涯的早期阶段创建了一个科学网络。
英文摘要
The integration of chemo- and biocatalysis offers a sustainable approach to making molecules which enables waste-free synthesis, catalytic or metal-free alternatives to current reagents, and a new way of building up molecular complexity whilst simplifying process complexity and cost. Approaching synthesis from this perspective will be critical to future chemistry, where all inter-related factors (reagents, solvent, yields, intermediates, catalysts etc) can be systemically optimized for the best synthetic route. The challenges, however, are substantial - how can we create mutually compatible reaction conditions for both enzymes and chemo systems, given the often vastly different requirements (notably of temperature and solvent)?The integration of chemocatalysis and biocatalysis represents an emerging area of research that will be central to the future chemical and manufacturing industries, activities that are crucial to the welfare and operation of our society. The two regimes of catalysis are highly complementary, with chemocatalysis offering powerful C-C bond strategies that can be merged with asymmetric functional group transformations controlled by an enzyme - an approach that is inspired by the ideality of biosynthesis. Arylation without recourse to precious metal catalysis is challenging and highly influential to current thinking in chemistry, creating high impact publications for the iCAT student engaged on the project. The project will provide training in areas such as biocatalysis, photoredox catalysis, organocatalysis, protein expression and purification, biological assay, asymmetric synthesis, and aqueous chemistry, meeting the mission statement of the CDT to create the next generation of scientist who can operate across the chemical continuum and is equipped for future Leadership roles in a changing, agile industry. The project has grown from a long-standing collaboration between the Greaney and Turner laboratories in integrated catalysis that has produced advances in bio-redox and C-H arylation, providing a supportive framework of co-workers, equipment and ideas in which the iCAT student can realise the ambitious goals of the research. Both the Turner and Greaney groups collaborate extensively with industrial groups (e.g. Syngenta, AZ, GSK) around the arylation and biocatalysis transformation concepts set out in the proposal, bringing end-user interactions to the project and helping the student create a scientific network in the early stages of their research career.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金